Note 7 - Inventory |
12 Months Ended | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2020 | |||||||||||||||||||||||
| Notes to Financial Statements | |||||||||||||||||||||||
| Inventory Disclosure [Text Block] |
The components of net inventory at December 31, 2020 are as follows:
During
2020, we utilized $11,000 of materials inventory for process development purposes. Also during 2020, we allocated $39,000 of finished goods inventory for use in clinical trials. Both of these transactions were recorded in research and development expense in the consolidated statement of operations. See Note 1 (h). |
||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|